Avadel Pharmaceuticals (AVDL) Other Working Capital Changes: 2009-2024
Historic Other Working Capital Changes for Avadel Pharmaceuticals (AVDL) over the last 16 years, with Dec 2024 value amounting to -$828,000.
- Avadel Pharmaceuticals' Other Working Capital Changes fell 300100.00% to -$3.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$30.9 million, marking a year-over-year decrease of 3033.65%. This contributed to the annual value of -$828,000 for FY2024, which is 138.42% down from last year.
- Avadel Pharmaceuticals' Other Working Capital Changes amounted to -$828,000 in FY2024, which was down 138.42% from $2.2 million recorded in FY2023.
- In the past 5 years, Avadel Pharmaceuticals' Other Working Capital Changes ranged from a high of $2.2 million in FY2023 and a low of -$30.9 million during FY2022.
- Its 3-year average for Other Working Capital Changes is -$9.9 million, with a median of -$828,000 in 2024.
- Per our database at Business Quant, Avadel Pharmaceuticals' Other Working Capital Changes skyrocketed by 156.63% in 2021 and then plummeted by 3,033.65% in 2022.
- MRY analysis of 5 years shows Avadel Pharmaceuticals' Other Working Capital Changes stood at -$1.9 million in 2020, then skyrocketed by 156.63% to $1.1 million in 2021, then crashed by 3,033.65% to -$30.9 million in 2022, then soared by 106.96% to $2.2 million in 2023, then plummeted by 138.42% to -$828,000 in 2024.
- Its Other Working Capital Changes was -$828,000 in FY2024, compared to $2.2 million in FY2023 and -$30.9 million in FY2022.